TickerFacts.

CapsoVision, Inc (CV): Shareholders' Equity

Annual figures by period end, from SEC filings.

$13.26M
As of 2025-12-31
$13.17M
As of 2026-06-30
2024-12-31: -$129.51M2025-12-31: $13.26M$13.26M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$13.26Mn/m2026-03-26, Balance as of period end
2024-12-31-$129.51Mn/a2026-03-26, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
CapsoVision, Inc (CV)2025-12-31$13.26Mn/m
Hyperfine, Inc. (HYPR)2025-12-31$41.01M-16.4%
Escalon Medical Corp (ESMC)2026-06-30$5.93M+209.5%
QT Imaging Holdings, Inc. (QTI)2025-12-31$6.45Mn/m
Nuwellis, Inc. (NUWE)2025-12-31$2.62M-59.8%
Precision Optics Corporation, Inc. (POCI)2026-06-30$20.35M+66.0%
electroCore, Inc. (ECOR)2025-12-31-$1.71Mn/m
Stereotaxis, Inc. (STXS)2025-12-31$13.48M+121.7%
Neuraxis, Inc (NRXS)2025-12-31$3.40M+64.4%

Compare CV, HYPR, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗